A Unified Deep Graph Model for Identifying the Molecular Categories of Ligands Targeting Nuclear Receptors

To fulfill functions for differentially regulating the downstream signaling pathways, functional ligands (i.e., agonists or antagonists) targeting nuclear receptors (NRs) are designed to stabilize different conformations (active or inactive) of the proteins. However, in practical applications, it is usually difficult to determine the molecular category of an NR ligand because these molecules all bind in the same location of an NR protein, namely, the ligand-binding pocket (LBP). Considering that ligands with different properties (agonists or antagonists) prefer to bind with differential conformations of NRs, it is possible to identify the molecular type of a given ligand through the differential binding environment (active or inactive conformations) of the protein-ligand interaction. Therefore, in this study, we established a unified model (NRIGN) based on the deep graphic architecture to discriminate agonists and antagonists targeting 26 successful or in-clinical-trial NR targets. Our result shows that NRIGN achieves an excellent prediction accuracy (ACC >0.95) and is robust enough to be applied in various real-world scenarios, such as predicting the molecular type of ligands in crystallized NR structures, ligands with multiple NR activities, and ligands with their types altered by target mutations. The proposed model is expected to promote rational design of drugs targeting NR proteins.

Authors

Institutions

Publication Details

Journal
Journal of Chemical Information and Modeling
Published
2025-05-26
DOI
https://doi.org/10.1021/acs.jcim.5c00700
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Unified Deep Graph Model for Identifying the Molecular Categories of Ligands Targeting Nuclear Receptors

Zhiliang Jiang, Huiyong Sun, Tingjun Hou, Dejun Jiang et al.
Journal of Chemical Information and Modeling
Computational Drug Discovery Methods
article

A Unified Deep Graph Model for Identifying the Molecular Categories of Ligands Targeting Nuclear Receptors

Zhiliang Jiang, Huiyong Sun, Tingjun Hou, Dejun Jiang, Yingjing Qian, Chen Yin, Kexin Xu, Sutong Xiang, Kaimo Yang, Qirui Deng, Jingxuan Ge, Zi-Hao Wang
article en

Abstract

To fulfill functions for differentially regulating the downstream signaling pathways, functional ligands (i.e., agonists or antagonists) targeting nuclear receptors (NRs) are designed to stabilize different conformations (active or inactive) of the proteins. However, in practical applications, it is usually difficult to determine the molecular category of an NR ligand because these molecules all bind in the same location of an NR protein, namely, the ligand-binding pocket (LBP). Considering that ligands with different properties (agonists or antagonists) prefer to bind with differential conformations of NRs, it is possible to identify the molecular type of a given ligand through the differential binding environment (active or inactive conformations) of the protein-ligand interaction. Therefore, in this study, we established a unified model (NRIGN) based on the deep graphic architecture to discriminate agonists and antagonists targeting 26 successful or in-clinical-trial NR targets. Our result shows that NRIGN achieves an excellent prediction accuracy (ACC >0.95) and is robust enough to be applied in various real-world scenarios, such as predicting the molecular type of ligands in crystallized NR structures, ligands with multiple NR activities, and ligands with their types altered by target mutations. The proposed model is expected to promote rational design of drugs targeting NR proteins.

Journal of Chemical Information and ModelingVol. 65(11)
Central South University (CN), China Pharmaceutical University (CN), Zhejiang Pharmaceutical College (CN), Pharmaceutical Biotechnology (Czechia) (CZ), Zhejiang University of Technology (CN), Zhejiang University (CN)
National Natural Science Foundation of China, China Pharmaceutical University
Openalex Percentile: Top 87%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.